EUVIMEDEUVIMED entdecken
Crossref

The eIF5A hypusination inhibitor GC7 improves tolerance of pancreatic beta cells to ischemia/reperfusion

Hajar Ouahmi, Filippo Massa iD, Marc Cougnon, Isabelle Rubera iD, Gisèle Jarretou, Michel Tauc, Emmanuel Van Obberghen, Antoine Sicard, Didier F Pisani iD

American Journal of Physiology-Cell Physiology · 01.01.2026 · 330 (1) · C56-C69

DOI: 10.1152/ajpcell.00631.2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.01.2026. Verfasst von Hajar Ouahmi und 8 weiteren Autor:innen. Beteiligte Einrichtung: LP2M, Université Côte d'Azur, CNRS, France. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Reperfusion Injury, Peptide Initiation Factors, RNA-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Fondation pour la Recherche Médicale (FRM), Société Francophone du Diabète (SFD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of rodent beta cell line with GC7, an inhibitor of eIF5A hypusination, reversibly slows down mitochondrial activity and shifts the cells’ energy metabolism toward anaerobic glycolysis. As a result, GC7 treatment transiently inhibits ATP production and insulin secretion in response to glucose. These changes enhance the resistance of pancreatic beta cell line to ischemia/reperfusion by reducing oxidative stress and improving cell survival, highlighting the potential anti-ischemic benefits of GC7 for pancreatic islet transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsReperfusion InjuryPeptide Initiation FactorsRNA-Binding ProteinsAnimalsMiceRatsEukaryotic Translation Initiation Factor 5AOxidative StressMitochondriaInsulin SecretionInsulinCell SurvivalCell LineGlycolysisEnergy Metabolism

Stichwörter der Autor:innen

anoxiadiabetesmetabolismoxidative stresstransplantation

Substanzen

Eukaryotic Translation Initiation Factor 5APeptide Initiation FactorsRNA-Binding ProteinsInsulin

Autor:innen und Institutionen

  • LP2M, Université Côte d'Azur, CNRS, France.
  • Service de Néphrologie Dialyse et Transplantation, Hôpital Pasteur 2, CHU Nice, Nice, France.

ORCID-Profile: Filippo Massa, Isabelle Rubera, Didier F Pisani

Förderung

  • Fondation pour la Recherche Médicale (FRM)
  • Société Francophone du Diabète (SFD)

Zitieren

APA

Ouahmi, H., Massa, F., Cougnon, M., Rubera, I., Jarretou, G., Tauc, M., Van Obberghen, E., Sicard, A., & Pisani, D. F. (2026). The eIF5A hypusination inhibitor GC7 improves tolerance of pancreatic beta cells to ischemia/reperfusion. American Journal of Physiology-Cell Physiology, 330(1), C56-C69. https://doi.org/10.1152/ajpcell.00631.2025

Vancouver

Ouahmi H, Massa F, Cougnon M, Rubera I, Jarretou G, Tauc M, et al. The eIF5A hypusination inhibitor GC7 improves tolerance of pancreatic beta cells to ischemia/reperfusion. American Journal of Physiology-Cell Physiology. 2026;330(1):C56-C69. doi:10.1152/ajpcell.00631.2025

BibTeX
@article{Ouahmi2026,
  author = {Ouahmi, Hajar and Massa, Filippo and Cougnon, Marc and Rubera, Isabelle and Jarretou, Gisèle and Tauc, Michel and Van Obberghen, Emmanuel and Sicard, Antoine and Pisani, Didier F},
  title = {The eIF5A hypusination inhibitor GC7 improves tolerance of pancreatic beta cells to ischemia/reperfusion},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2026},
  volume = {330},
  number = {1},
  pages = {C56--C69},
  doi = {10.1152/ajpcell.00631.2025}
}
Kostenlos starten →